There’s a revolution occurring in cancer treatment, and it could mean the end of chemotherapy.
It’s called ibrutinib, and it’s a potential breakthrough in treating chronic lymphocytic leukemia (CLL) that could leave patients with fewer side effects than chemotherapy.
While more effective chemotherapy agents have improved cancer survival, not all patients benefit from the drugs.
Some 90% of cancer patients with metastatic breast, prostate, lung or colon cancers develop resistance to chemotherapy, and now scientists may have a clue as to why
On Monday, Good Morning America anchor Robin Roberts announced to viewers that she has been diagnosed with myelodysplastic syndrome, a blood and bone marrow disease once known as preleukemia. Roberts, who beat breast cancer five …
Just 4% of women of childbearing age with cancer take steps to mitigate the risks of infertility inherent in many treatments.
The first in a two-part series investigating why critical prescription drugs are in short supply in the U.S.
Ovarian cancer causes more deaths than any other reproductive cancer, largely because there is little doctors can do to prolong women’s lives after they are diagnosed. Surgery can remove the most obvious growths and chemotherapy …
(Updated) Imagine you are a single mother suffering from depression, overwhelmed with caring for an autistic, nonverbal and developmentally disabled son. If he were diagnosed with cancer, what would you do?
Thanks to remarkable advances in both detecting and treating cancer, young children who are diagnosed with various forms of the disease have an 80% chance of surviving into healthy adulthood.
Can you have chemo and keep your hair? According to the Washington Post, the answer is probably yes — that is, if you are willing to subject yourself to wearing icy caps set at a skull-chilling -30 Fahrenheit that can cost …
The Food and Drug Administration (FDA) is recommending that the approval of Avastin for the treatment of breast cancer be revoked.
Researchers have discovered gene mutations in patients with acute myeloid leukemia (AML) that may help doctors determine which treatments will work best for which patients early on.